Skip to content

Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial

Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04470193
Enrollment
50
Registered
2020-07-14
Start date
2019-06-10
Completion date
2020-03-19
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children With Medical Complexity

Keywords

medical complexity, multiple chronic conditions, children

Brief summary

The investigators have developed a tool to facilitate self-management for children with medical complexity (complex, multisystem chronic diseases) called MyChildCMC (My Child's Complex Medical Condition). MyChildCMC is an online, phone application (app) that engages parents daily in ongoing monitoring of common, crosscutting acute symptoms, including respiratory distress, inadequate feeding/fluid intake, fever, altered mental status, pain, and seizure status. The MyChildCMC app also guides parents to recognize early warning signs for health deteriorations to avoid acute events (i.e., ED visits and/or hospitalizations). Parent comments during the development of the MyChildCMC application revealed that the tool had potential in helping them manage their child's chronic conditions. This study will be the first to explore if online home monitoring using online technology is feasible, scalable, and can lead to improved CMC outcomes. This pilot trial for the MyChildCMC app was designed to determine preliminary impact by comparing outcomes (child QOL, child emergency department and hospital admissions, and parent/caregiver satisfaction with care) between the intervention and control groups. If successful, our approach will be a model for improving CMC care and reducing costs for families and children with medical complexity. Future MyChildCMC trials will integrate care coordination and a more robust alert system to help facilitate care and follow-up for patients.

Detailed description

Aim: Investigators will assess the impact of the MyChildCMC app by comparing the following outcomes for the child and caregiver: 1. Child Quality of Life (QOL) 2. Child Emergency Department (ED) and hospital admissions 3. Number of hospital days 4. Parent/Caregiver satisfaction with care

Interventions

OTHERMyChildCMC app

Patients/parents will self-monitor their symptoms daily using the MyChildCMC app completing the daily vitals form. After patient/parents complete the daily form, the app provides in-app alerts and graphs showing symptom data over time.

Sponsors

HRSA/Maternal and Child Health Bureau
CollaboratorFED
University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

Participant Inclusion Criteria: Children with complex medical conditions\* ages 1 through 20 years with their primary caregiver (primary person caring for the child) who: * have been seen at Primary Children's Hospital within 365 days, * own a smartphone or a tablet computer with Internet access, and * are English speaking \*Physician diagnosis was used to determine CMC diagnosis

Exclusion criteria

* Critically ill children in imminent death * Non-English speakers

Design outcomes

Primary

MeasureTime frameDescription
Patient Quality of Life (QOL)Quality of Life assessed at baseline, then compared to 1 month and 3 months from start of study/interventionCompared Mean QOL Change from Baseline to Each Follow-up Assessment Between the Two study Groups, using the Ellzey et. al.'s QOL survey questionnaire for children with complex medical conditions, which assesses multiple domains including physical health, mental health, sleep, pain, activities and general QOL. The total QOL score was reported and standardized to 100 points, with scores ranging from 20 (the lowest QOL) to 100 (the highest QOL). Higher QOL scores represent a better outcome.

Secondary

MeasureTime frameDescription
Patient Emergency Department (ED)/HospitalizationChange in ED/hospital admission between 3-month prior and 3-month post start of study/interventionCompare NUMBER of ED and hospital admissions 3-month pre, and 3-month post study initiation between the intervention and Usual care groups.
Number of Hospital Days3-month pre and 3-month post study startNumber of days (duration) participants were hospitalized
Parent/Caregiver Satisfaction With CareCollected once at study end (3 months)Caregiver satisfaction with overall care of their children, using an adapted version (by Ellzey et. al) of Client Satisfaction Questionnaire for children with complex medical conditions, which has 6 questions measuring caregiver's confidence with ability to take care of child's health, consistency in doing things needed to take care of the child, availability of medical professional support, availability of social support, availability of a monitory system to help with child's home care and stress about child's health. We reported the total caregiver satisfaction scores, which range from 5 (the lowest satisfaction) to 30 (the highest satisfaction). Higher caregiver satisfaction scores represent a better outcome.

Countries

United States

Participant flow

Recruitment details

Recruitment period was between June 2019 to December 2019. Recruitment occurred at Primary Children's Hospital in Salt Lake City, Utah.

Pre-assignment details

Of the 68 subjects whose medical records were reviewed, 6 did NOT meet eligibility criteria (5 non-English speaking parents and 1 was on palliative care) and were NOT invited to participate. Of the 62 POTENTIALLY eligible subjects who were invited to participate in the study, 12 DECLINED to participate and WERE NOT enrolled, and 50 subjects AGREED to participate and were enrolled. Of the 50 subjects who were enrolled, 24 were randomized to MyChildCMC and 26 to usual care.

Participants by arm

ArmCount
MyChildCMC Intervention Group
Parents/patients randomized into the MyChildCMC Intervention Group will use the MyChildCMC app to monitor their child's daily symptoms for the duration of the study period (3 months). The MyChildCMC app includes a daily form consisting of 12 questions assessing child's vitals, pain, seizures, mood, and feeding as well as caregiver worry for the day. Daily reminders are sent to the parent to fill out the vitals form in the app. Parents/participants will also fill out a quality of life survey at baseline, 1 month, and 3 months as well as a caregiver satisfaction survey at 3 months. MyChildCMC app: Patients/parents will self-monitor their symptoms daily using the MyChildCMC app completing the daily vitals form. After patient/parents complete the daily form, the app provides in-app alerts and graphs showing symptom data over time.
24
Usual Care Group
Parents/patients randomized into the Usual Care Group do not use the MyChildCMC app to monitor their child's daily symptoms and are instructed to continue with regular care for their child and to continue monitoring their child's symptoms on their own without the use of the app for the duration of the study period (3 months). Parents/participants will also fill out a quality of life survey at baseline, 1 month, and 3 months as well as a caregiver satisfaction survey at 3 months.
26
Total50

Baseline characteristics

CharacteristicMyChildCMC Intervention GroupUsual Care GroupTotal
Age, Categorical
<=18 years
24 Participants24 Participants48 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants2 Participants2 Participants
Age, Continuous7.29 years9.65 years8.52 years
Race/Ethnicity, Customized
Hispanic
3 Participants8 Participants11 Participants
Race/Ethnicity, Customized
Other
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
White
20 Participants18 Participants38 Participants
Region of Enrollment
United States
24 participants26 participants50 participants
Sex: Female, Male
Female
9 Participants12 Participants21 Participants
Sex: Female, Male
Male
15 Participants14 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 240 / 26
other
Total, other adverse events
0 / 240 / 26
serious
Total, serious adverse events
0 / 240 / 26

Outcome results

Primary

Patient Quality of Life (QOL)

Compared Mean QOL Change from Baseline to Each Follow-up Assessment Between the Two study Groups, using the Ellzey et. al.'s QOL survey questionnaire for children with complex medical conditions, which assesses multiple domains including physical health, mental health, sleep, pain, activities and general QOL. The total QOL score was reported and standardized to 100 points, with scores ranging from 20 (the lowest QOL) to 100 (the highest QOL). Higher QOL scores represent a better outcome.

Time frame: Quality of Life assessed at baseline, then compared to 1 month and 3 months from start of study/intervention

Population: Analysis included 50 participants at baseline (including 24 participants in the intervention group and 26 in the usual care group ), 40 participants at 1 months (including 16 in the intervention group and 24 in the usual care group), and 37 participants at 3 months (including 15 participants in the intervention and 22 participants in the usual care group).

ArmMeasureGroupValue (MEAN)Dispersion
MyChildCMC Intervention GroupPatient Quality of Life (QOL)Baseline QOL score62.7 score on a scale, range from 20 to 100Standard Deviation 14.8
MyChildCMC Intervention GroupPatient Quality of Life (QOL)1-month QOL score59.8 score on a scale, range from 20 to 100Standard Deviation 16.9
MyChildCMC Intervention GroupPatient Quality of Life (QOL)3-month QOL score55.2 score on a scale, range from 20 to 100Standard Deviation 15.3
Usual Care GroupPatient Quality of Life (QOL)Baseline QOL score54.4 score on a scale, range from 20 to 100Standard Deviation 15
Usual Care GroupPatient Quality of Life (QOL)1-month QOL score51.9 score on a scale, range from 20 to 100Standard Deviation 12.2
Usual Care GroupPatient Quality of Life (QOL)3-month QOL score50.8 score on a scale, range from 20 to 100Standard Deviation 15.6
Comparison: We used a generalized estimating equation model for repeated assessments, with a common unstructured residual covariance matrix to account for correlation in repeated measurements in the same patient, to compare QoL total score at baseline, 1 month, and 3 months between the groups. We hypothesized that MyChildCMC users would have better outcomes for the child (higher QoL, fewer ED and/or hospital use and hospital days) and parent (higher satisfaction with child's care).p-value: >0.05generalized estimating equation model
Secondary

Number of Hospital Days

Number of days (duration) participants were hospitalized

Time frame: 3-month pre and 3-month post study start

Population: Number of hospital days were compared between the Intervention group participants and Usual Care group participants.

ArmMeasureGroupValue (MEAN)Dispersion
MyChildCMC Intervention GroupNumber of Hospital Days3-Month Pre9.25 DaysStandard Deviation 18.3
MyChildCMC Intervention GroupNumber of Hospital Days3-Month Post4.54 DaysStandard Deviation 6.95
Usual Care GroupNumber of Hospital Days3-Month Pre1.08 DaysStandard Deviation 1.88
Usual Care GroupNumber of Hospital Days3-Month Post2.46 DaysStandard Deviation 3.84
p-value: <0.00195% CI: [0.39, 0.62]Mixed Models Analysis
Secondary

Parent/Caregiver Satisfaction With Care

Caregiver satisfaction with overall care of their children, using an adapted version (by Ellzey et. al) of Client Satisfaction Questionnaire for children with complex medical conditions, which has 6 questions measuring caregiver's confidence with ability to take care of child's health, consistency in doing things needed to take care of the child, availability of medical professional support, availability of social support, availability of a monitory system to help with child's home care and stress about child's health. We reported the total caregiver satisfaction scores, which range from 5 (the lowest satisfaction) to 30 (the highest satisfaction). Higher caregiver satisfaction scores represent a better outcome.

Time frame: Collected once at study end (3 months)

ArmMeasureValue (MEAN)Dispersion
MyChildCMC Intervention GroupParent/Caregiver Satisfaction With Care26.93 score on a scale, ranging from 5 to 30Standard Deviation 2.22
Usual Care GroupParent/Caregiver Satisfaction With Care24.14 score on a scale, ranging from 5 to 30Standard Deviation 4.21
p-value: 0.03595% CI: [1.01, 1.22]Mixed Models Analysis
Secondary

Patient Emergency Department (ED)/Hospitalization

Compare NUMBER of ED and hospital admissions 3-month pre, and 3-month post study initiation between the intervention and Usual care groups.

Time frame: Change in ED/hospital admission between 3-month prior and 3-month post start of study/intervention

Population: Using intention-to-treat analysis, we compared numbers of ED/hospital admissions and hospital days (3-month pre- and 3-month post-enrollment; enrollment hospitalization excluded) between the groups using generalized linear models with logarithmic link and Poisson regression analysis, estimating rate ratios (RR) and 95% confidence intervals (CI). Covariates included age, sex, and race/ethnicity.

ArmMeasureGroupValue (MEAN)Dispersion
MyChildCMC Intervention GroupPatient Emergency Department (ED)/Hospitalization3-month pre-study1.13 number of ED and hospital admissionsStandard Deviation 1.26
MyChildCMC Intervention GroupPatient Emergency Department (ED)/Hospitalization3-month post-study1.08 number of ED and hospital admissionsStandard Deviation 1.25
Usual Care GroupPatient Emergency Department (ED)/Hospitalization3-month pre-study0.85 number of ED and hospital admissionsStandard Deviation 1.05
Usual Care GroupPatient Emergency Department (ED)/Hospitalization3-month post-study0.88 number of ED and hospital admissionsStandard Deviation 1.11
p-value: 0.88295% CI: [0.58, 1.88]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026